comprehensive -WSS

comprehensive

author：entertainment 2025-10-02 05:38:35 - browse：3368

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Surprise medical billing ban raises prices elsewhere

leisure time

WSS

FDA warns medical device makers about rise in fabricated data

MD Anderson's Padmanee Sharma responds to research credit suit

HIV drugs protect against transmission, even in unprotected sex

Reporting on presidential health from Reagan to Trump and Biden

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Reporting on presidential health from Reagan to Trump and Biden

focus

comprehensive

entertainment

23andMe had bad news about my health. I wish a person had delivered it

Secretariat’s lessons for human medicine

As demand for Covid shots wanes, Moderna seeks its next success

Innovation in antibiotics is ailing. 'Brain drain' may kill it

State Dept. review finds Biden bears some blame for Afghanistan failures

Flagship Pioneering startup Sonata Therapeutics lays off 21

Tori Bowie and the unacceptable rates of Black maternal death

Medicare Advantage enrollment hits roughly 33.4 million

Cancer drug shortages should be causing more outrage

Measles policy set amid Florida outbreak alarms vaccine proponents

entertainment

At ASCO, AstraZeneca reports strong data for breast cancer drug

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

With trial win, GSK could get blood cancer drug back on market

Ukraine seeks to reclaim its role as a hub for clinical trials

Let's speed up science by embracing open access publishing

Let's speed up science by embracing open access publishing

focus

leisure time

entertainment

focus